LRA Congratulates GSK on FDA Approval of Benlysta® (belimumab) for Children with Lupus Nephritis
NEW YORK, NY. July 27, 2022. The Lupus Research Alliance (LRA) is pleased to share that the U.S. Food...
Benlysta
Promise of Additional Lupus Therapies Highlighted at ACR 2021 Annual Meeting
November 9, 2021
Results of clinical trials testing many existing and potential lupus treatments were highlighted at the American College...
Independent Panel Gives High Marks to New Lupus Nephritis Therapies, Policies Reflect LRA Feedback
April 20, 2021
At a public meeting in March led by the Institute for Clinical and Economic Review (ICER), an...
LRA Pleased to Share GSK’s Benlysta® (belimumab) is First Lupus Nephritis Treatment Approved by FDA
NEW YORK, NY. December 17, 2020. The Lupus Research Alliance (LRA) congratulates GSK on the U.S. Food and Drug...
LRA Applauds GSK on Positive Phase 3 Study of Benlysta® in Lupus Nephritis
September 16, 2020
NEW YORK, NY. The Lupus Research Alliance welcomes positive BLISS-LN Phase 3 data published in this week’s...
New Data Showed Safety and Effectiveness of Benlysta for Kids
July 27, 2020
A new international study published in Annals of the Rheumatic Diseases showed that belimumab (Benlysta) was safe...
Research Shows Benefit to Starting Belimumab Sooner Rather Than Later
April 16, 2020
Treating people with lupus earlier with belimumab (Benlysta) may work better than as a last option according...
LRA Shares Excitement For What’s Ahead in Lupus Nephritis
January 16, 2020
Up to half of people with lupus will have lupus nephritis – damage to the kidneys that...
LRA Celebrates Major Research Breakthroughs in 2019
January 7, 2020
2019 was a phenomenal, breakthrough year for lupus research on both the clinical development and basic science...
New Phase 3 Study Shows Positive Results for Benlysta® in Lupus Nephritis
December 17, 2019
The Lupus Research Alliance is thrilled to share exciting news from GSK that Benlysta (belimumab) demonstrated positive...
Breadth of Clinical Research Presented at the 2019 ACR/ARP Annual Meeting Brings Hope for New Lupus Treatments
November 14, 2019
The Lupus Research Alliance staff was on the ground at the 2019 ACR/ARP Annual Meeting and highly...
New Study Shows Benlysta Alters B Cells in People with Lupus
August 21, 2019
Newly published research found that belimumab (Benlysta®) effectively reduced the number of B cells, a type of...